共 50 条
- [42] WHEN TO DISCONTINUE THERAPY IN PEMPHIGUS VULGARIS ZEITSCHRIFT FUR HAUTKRANKHEITEN H&G, 1986, 61 (22): : 1596 - &
- [45] Adjuvant therapy of pemphigus vulgaris and pemphigus foliaceus with intravenous immunoglobulin HAUTARZT, 1998, 49 (10): : 774 - 776
- [46] Adjuvant therapy for pemphigus vulgaris and pemphigus foliaceus with intravenous immunoglobulin HAUTARZT, 1999, 50 (05): : 372 - 373
- [48] Unexpected B lymphocytes depletion in a patient with pemphigus vulgaris after a single dose of 50 mg rituximab JOURNAL OF DERMATOLOGY, 2024, 51 (10): : e365 - e366
- [50] Antigen-specific B cell depletion with desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) for targeted therapy of mucosal pemphigus vulgaris JOURNAL OF IMMUNOLOGY, 2020, 204 (01):